Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioluminescence Ventures is a San Francisco-based venture capital firm investing in early-stage biotechnology and life sciences startups developing first-in-class or best-in-class therapeutics. The firm manages $477 million across two funds and focuses on breakthrough biology, drug discovery platforms, genetic medicines platforms, and computational biology platforms. It has invested in notable biotechs such as Ensoma (cell/gene therapy), Nido Biosciences (neuromuscular disease), ReCode Therapeutics (mRNA/gene correction), Surge Therapeutics (immunotherapy), and Cerevance (CNS therapeutics).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioluminescence Ventures.